Background: The association between higher New York Heart Association(NYHA) class and outcomes in patients with heart failure and preserved systolic function is not well known. Methods: We performed a retrospective fo...Background: The association between higher New York Heart Association(NYHA) class and outcomes in patients with heart failure and preserved systolic function is not well known. Methods: We performed a retrospective follow- up study of 988 patients with heart failure with ejection fraction >45% who participated in the DIG trial. Using Cox proportional hazard models, we estimated risks of all- cause mortality, heart failure mortality, all- cause hospitalization, and hospitalization due to worsening heart failure during a median follow- up of 38.5 months. Results: Patients had a median age of 68 years; 41.2% were women and 13.9% , nonwhites. Overall, 23.4% of patients died, and 19.9% were hospitalized because of worsening heart failure. Proportion of patients with NYHA classes I, II, III, and IV were 19.9% , 58.0% , 20.9% , and 1.2% , respectively, and 14.7% , 21.1% , 35.9% , and 58.3% , respectively, died of all causes(P< .001 for trend). Respective rates for heart failure related hospitalizations were 14.2% , 17.1% , 32.5% , and 33.3% (P< .001 for trend). Compared with NYHA class I patients, adjusted hazard ratios(HRs) for all- cause mortality for class II, III, and IV patients were 1.54(95% CI 1.02- 2.32, P=.042), 2.56(95% CI 1.64- 24.01, P< .001), and 8.46(95% CI 3.57- 20.03, P< .001), respectively. Respective adjusted HRs(95% CI) for hospitalization due to heart failure for class II, III, and IV patients were 1.16(0.76- 1.77)(P=.502), 2.27(1.45- 3.56)(P< .001), and 3.71(1.25- 11.02)(P=.018). New York Heart Association classes II through IV were also associated with higher risk of all- cause hospitalization. Conclusion: Higher NYHA classes were associated with poorer outcomes in patients with heart failure and preserved systolic function.展开更多
1 简介 欧洲心脏病协会(European Society of Cardiology,ESC )实践指南委员会(CPG )认识到新的临床研究试验将对当前的指南建议产生影响。为了保持指南同实践的与时俱进,有必要根据最新的临床证据对建议和证据水平进行适当调整。当前...1 简介 欧洲心脏病协会(European Society of Cardiology,ESC )实践指南委员会(CPG )认识到新的临床研究试验将对当前的指南建议产生影响。为了保持指南同实践的与时俱进,有必要根据最新的临床证据对建议和证据水平进行适当调整。当前的心力衰竭(心衰)诊疗指南颁布于2008 年,而心脏起搏治疗指南则发表于2007 年。2010 心衰设备治疗指南更新为CPG 首次颁布。实践指南建议应该反映循证医学的证据。展开更多
目的分析血清脑钠肽、降钙素原变化与心力衰竭患者纽约心脏病协会(New York Heart Association,NYHA)分级的相关性。方法选取2019年5月—2023年2月云南省玉溪市第二人民医院收治的97例心力衰竭患者为研究对象,所有患者都进行NYHA心功能...目的分析血清脑钠肽、降钙素原变化与心力衰竭患者纽约心脏病协会(New York Heart Association,NYHA)分级的相关性。方法选取2019年5月—2023年2月云南省玉溪市第二人民医院收治的97例心力衰竭患者为研究对象,所有患者都进行NYHA心功能分级后分为3组,心功能Ⅱ级57例(Ⅱ级组),心功能Ⅲ级28例(Ⅲ级组),心功能Ⅳ级12例(Ⅳ级组),检测3组血清脑钠肽、降钙素原含量并进行相关性分析。结果随着NYHA分级的增加,患者的左室射血分数明显降低,左室舒张末期内径明显升高,差异有统计学意义(P均<0.05)。随着NYHA分级的增加,患者的血清脑钠肽、降钙素原含量明显升高,差异有统计学意义(P均<0.05)。Spearman分析显示NYHA分级与血清脑钠肽、降钙素原含量、左室射血分数、左室舒张末期内径存在相关性(r=0.714、0.746、-0.788、0.692,P均<0.05)。结论心力衰竭患者多伴随有血清脑钠肽、降钙素原的高表达,与患者的NYHA分级存在相关性,可作为判断患者病情的重要依据。展开更多
文摘Background: The association between higher New York Heart Association(NYHA) class and outcomes in patients with heart failure and preserved systolic function is not well known. Methods: We performed a retrospective follow- up study of 988 patients with heart failure with ejection fraction >45% who participated in the DIG trial. Using Cox proportional hazard models, we estimated risks of all- cause mortality, heart failure mortality, all- cause hospitalization, and hospitalization due to worsening heart failure during a median follow- up of 38.5 months. Results: Patients had a median age of 68 years; 41.2% were women and 13.9% , nonwhites. Overall, 23.4% of patients died, and 19.9% were hospitalized because of worsening heart failure. Proportion of patients with NYHA classes I, II, III, and IV were 19.9% , 58.0% , 20.9% , and 1.2% , respectively, and 14.7% , 21.1% , 35.9% , and 58.3% , respectively, died of all causes(P< .001 for trend). Respective rates for heart failure related hospitalizations were 14.2% , 17.1% , 32.5% , and 33.3% (P< .001 for trend). Compared with NYHA class I patients, adjusted hazard ratios(HRs) for all- cause mortality for class II, III, and IV patients were 1.54(95% CI 1.02- 2.32, P=.042), 2.56(95% CI 1.64- 24.01, P< .001), and 8.46(95% CI 3.57- 20.03, P< .001), respectively. Respective adjusted HRs(95% CI) for hospitalization due to heart failure for class II, III, and IV patients were 1.16(0.76- 1.77)(P=.502), 2.27(1.45- 3.56)(P< .001), and 3.71(1.25- 11.02)(P=.018). New York Heart Association classes II through IV were also associated with higher risk of all- cause hospitalization. Conclusion: Higher NYHA classes were associated with poorer outcomes in patients with heart failure and preserved systolic function.
文摘目的分析血清脑钠肽、降钙素原变化与心力衰竭患者纽约心脏病协会(New York Heart Association,NYHA)分级的相关性。方法选取2019年5月—2023年2月云南省玉溪市第二人民医院收治的97例心力衰竭患者为研究对象,所有患者都进行NYHA心功能分级后分为3组,心功能Ⅱ级57例(Ⅱ级组),心功能Ⅲ级28例(Ⅲ级组),心功能Ⅳ级12例(Ⅳ级组),检测3组血清脑钠肽、降钙素原含量并进行相关性分析。结果随着NYHA分级的增加,患者的左室射血分数明显降低,左室舒张末期内径明显升高,差异有统计学意义(P均<0.05)。随着NYHA分级的增加,患者的血清脑钠肽、降钙素原含量明显升高,差异有统计学意义(P均<0.05)。Spearman分析显示NYHA分级与血清脑钠肽、降钙素原含量、左室射血分数、左室舒张末期内径存在相关性(r=0.714、0.746、-0.788、0.692,P均<0.05)。结论心力衰竭患者多伴随有血清脑钠肽、降钙素原的高表达,与患者的NYHA分级存在相关性,可作为判断患者病情的重要依据。
